Clareo Health | Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ViiV Healthcare
With
Pfizer
Age
18–85
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Stable Renal Function defined as ≤20% (25% for normal renal function) difference between 2 measurements of serum creatinine obtained on 2 occasions separated by at least 2 weeks.
Body Mass Index (BMI) of approximately 18 to 40 kg/m2 inclusive.
Total body weight \>50 kg (110 lbs).
Male or female subjects between the ages of 18 and 85 years.
You may not be if
Subjects with acute renal disease and/or history of renal transplant.
Supine BP at Screening ≥160 mm Hg systolic or ≥95 mm Hg diastolic.
Supine BP at Screening ≤80 mm Hg systolic or ≤40 mm Hg diastolic.
